What is the Out-of-Pocket Cost for Ubrelvy?
The out-of-pocket cost for Ubrelvy can vary significantly depending on insurance coverage, pharmacy, and dosage. Without insurance, a 30-day supply of Ubrelvy can cost several hundred dollars. For example, pricing may range from approximately $500 to $600 or more for a 30-day supply of either the 50 mg or 100 mg tablets [1].
Can I Get Financial Assistance for Ubrelvy?
Yes, there are programs that may help reduce the cost of Ubrelvy. The manufacturer, AbbVie, offers a savings card program for eligible patients. This program can lower out-of-pocket costs to as little as $20 for a 30-day supply, with a maximum savings of $120 per fill and an annual limit of $1,500 [1][2]. Eligibility for these savings programs typically depends on having commercial prescription drug insurance and meeting certain criteria. Patients without prescription insurance may not be eligible [2].
How Does Insurance Affect Ubrelvy Pricing?
Insurance coverage plays a crucial role in determining the final out-of-pocket cost for Ubrelvy. Many commercial insurance plans cover Ubrelvy, but the specific co-pay amount will vary by plan. It is advisable for patients to check with their insurance provider to understand their coverage details, including co-pays, deductibles, and whether prior authorization is required [1].
What is the Difference Between Ubrelvy 50 mg and 100 mg?
Ubrelvy is available in two strengths: 50 mg and 100 mg [1]. The 100 mg dose is typically prescribed for acute treatment of migraine with or without aura in adults. The 50 mg dose may also be used for the acute treatment of migraine. The choice of dosage depends on individual patient needs and physician recommendations [3].
When Does Ubrelvy Patent Exclusivity End?
The patent exclusivity for Ubrelvy (ubrogepant) is a key factor influencing its long-term availability and potential for generic competition. Information regarding specific patent expiry dates and any associated litigation or challenges can be found on specialized databases that track drug patents [4].
Who Manufactures Ubrelvy?
Ubrelvy is manufactured by AbbVie [1].
What Are Other Treatment Options for Migraine?
Ubrelvy is a medication used for the acute treatment of migraine. Other acute treatment options for migraine can include triptans, other CGRP receptor antagonists, or combination analgesics. For preventive treatment of migraines, options may include certain antihypertensives, antidepressants, anticonvulsants, or CGRP monoclonal antibodies [5].
---
Sources
1. AbbVie. Ubrelvy Savings Card. https://www.ubrelvy.com/savings-card
2. Ubrelvy. Cost & Savings. https://www.ubrelvy.com/cost-and-savings
3. Ubrelvy Prescribing Information. https://www.ubrelvy.com/prescribing-information
4. DrugPatentWatch.com. https://drugpatentwatch.com/
5. Mayo Clinic. Migraine. https://www.mayoclinic.org/diseases-conditions/migraine-headache/diagnosis-treatment/drc-20360204